| Code | Description | Claims | Beneficiaries | Total Paid |
| 97802 |
|
842 |
839 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,074 |
1,012 |
$14K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
238 |
163 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
238 |
184 |
$13K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
539 |
500 |
$9K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
292 |
291 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
252 |
252 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
189 |
189 |
$6K |
| 90686 |
|
456 |
455 |
$4K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
227 |
226 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
64 |
64 |
$2K |
| 96156 |
|
61 |
61 |
$2K |
| 90688 |
|
245 |
245 |
$2K |
| 99199 |
Unlisted special service, procedure or report |
34 |
30 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
41 |
41 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
141 |
109 |
$1K |
| 92081 |
|
43 |
43 |
$1K |
| 90670 |
|
96 |
96 |
$846.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
16 |
$814.96 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
79 |
78 |
$733.32 |
| 90685 |
|
68 |
66 |
$513.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$471.16 |
| 90633 |
|
52 |
52 |
$468.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$446.07 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
103 |
100 |
$352.83 |
| 90647 |
|
41 |
41 |
$351.00 |
| 90651 |
|
32 |
32 |
$288.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$278.76 |
| 80061 |
Lipid panel |
26 |
26 |
$228.40 |
| 90723 |
|
27 |
27 |
$225.00 |
| 90680 |
|
25 |
25 |
$207.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
26 |
26 |
$189.93 |
| 85018 |
|
116 |
116 |
$174.25 |
| 82947 |
|
64 |
54 |
$173.31 |
| 83655 |
|
29 |
29 |
$161.74 |
| 80053 |
Comprehensive metabolic panel |
30 |
29 |
$137.85 |
| 90734 |
|
13 |
13 |
$117.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$101.40 |
| 90649 |
|
13 |
13 |
$72.00 |
| 96127 |
|
54 |
54 |
$19.04 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
57 |
57 |
$0.03 |
| 1036F |
|
2,552 |
2,355 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,678 |
2,477 |
$0.00 |
| 3008F |
|
1,698 |
1,634 |
$0.00 |
| 1126F |
|
16 |
15 |
$0.00 |
| 36416 |
|
69 |
59 |
$0.00 |
| 3074F |
|
33 |
29 |
$0.00 |
| 1170F |
|
13 |
13 |
$0.00 |
| 1160F |
|
207 |
181 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
460 |
427 |
$0.00 |
| 1159F |
|
206 |
181 |
$0.00 |
| 3078F |
|
101 |
93 |
$0.00 |
| 0502F |
|
123 |
90 |
$0.00 |
| 4120F |
|
31 |
30 |
$0.00 |
| 97803 |
|
12 |
12 |
$0.00 |
| 1033F |
|
42 |
41 |
$0.00 |
| 99401 |
|
61 |
61 |
$0.00 |
| 3725F |
|
27 |
27 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
16 |
16 |
$0.00 |